| Name | Title | Contact Details |
|---|
Aaron Diamond AIDS Research Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SelectCare is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tocagen is a clinical stage, biopharmaceutical company pursuing the discovery, development and commercialization of gene therapy products for the treatment of cancer.
Fremont Area Medical Center is a Fremont, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.